Moreover, in many renal cancer cell lines and clinical samples, expression of RIPK3 is frequently silenced through promoter methylation or other epigenetic mechanisms, thereby preventing activation of the necroptotic cascade (Geserick et al., 2015; Ganini et al., 2022). The gene discussed is RIPK3; the disease is renal carcinoma.